StonvexLoading…
StonvexStonvexStonvexCore line items from ATKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.85B | $3.20B | $3.52B | $3.91B |
Operating Income | $23.17M | $624.78M | $893.49M | $1.23B |
Net Income | $-15.18M | $472.87M | $689.90M | $913.43M |
EPS (Diluted) | $-0.45 | $12.69 | $17.27 | $20.30 |
Total Assets | $2.85B | $3.02B | $2.94B | $2.60B |
Total Liabilities | $1.45B | $1.48B | $1.47B | $1.35B |
Cash & Equivalents | $506.70M | $351.38M | $388.11M | $388.75M |
Free Cash Flow OCF − CapEx | $295.65M | $399.17M | $588.75M | $651.06M |
Shares Outstanding | 33.67M | 34.86M | 37.32M | 41.35M |